Research programme: coronavirus inhibitors - Shire/USAMRIID
Latest Information Update: 22 Dec 2016
At a glance
- Originator United States Army Medical Research Institute of Infectious Diseases; ViroPharma
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Coronavirus infections
Most Recent Events
- 12 May 2003 Preclinical trials in Coronavirus infections in USA (unspecified route)